Additional file 1: of Use of glatiramer acetate between 2010â2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients

12883_2019_1383_MOESM1_ESM.docx (15.99 kB)

Additional file 1: of Use of glatiramer acetate between 2010â2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients

journal contribution

posted on 2019-07-12, 05:00 authored by Chiara Zecca, Giulio Disanto, Rosaria Sacco, Gianna Riccitelli, Claudio Gobbi

Comparison between the baseline characteristics of patients monitored (V1âV2) and those who had no data on V2 (noV1âV2). (DOCX 15 kb)

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC